Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Tumor Biology

Bottom-up Histogenesis of Colorectal Adenomas

Origin in the Monocryptal Adenoma and Initial Expansion by Crypt Fission

Sean L. Preston, Wai-Man Wong, Annie On-On Chan, Richard Poulsom, Rosemary Jeffery, Robert A. Goodlad, Nikki Mandir, George Elia, Marco Novelli, Walter F. Bodmer, Ian P. Tomlinson and Nicholas A. Wright
Sean L. Preston
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wai-Man Wong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie On-On Chan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Poulsom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosemary Jeffery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Goodlad
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikki Mandir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Elia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Novelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter F. Bodmer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian P. Tomlinson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas A. Wright
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published July 2003
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The adenoma:carcinoma sequence is well established. Understanding the molecular pathology of the adenoma is therefore important. There is great controversy within the field. The Vogelstein group champions the “top-down” theory (colorectal adenomas arise and grow across the mucosal surface and down into the crypts), whereas other studies, including our own, propose “bottom-up” spread. Serial sections of 40 small (<3 mm) sporadic colorectal adenomas were stained with H&E, MIB-1, and for β-catenin. 10 early adenomas were Feulgen-stained and microdissected. We also examined the flat mucosa of three patients who had undergone colectomies for familial adenomatous polyposis (FAP) and specimens from a XO/XY individual with FAP, the latter using in situ hybridization for the Y chromosome. In the earliest sporadic adenomas, there were crypts entirely filled with adenomatous epithelium, which showed proliferative activity and nuclear localization of β-catenin. There was a sharp cutoff between crypt epithelial cells showing nuclear β-catenin and surface cells with membrane staining. In slightly larger lesions, adenomatous spread from above was seen. Microdissected adenomas showed multiple fission events, with proliferation distributed equally throughout. In FAP tissue, numerous isolated monocryptal adenomas, which were clonal in origin, were seen. Examination of adenomas in the XO/XY individual showed no instances of XY or XO adenomatous epithelium growing down into crypts of the other genotype. Both sporadic and FAP adenomas start as a unicryptal adenomas and grow initially by crypt fission—a bottom-up pattern. Later, in sporadic adenomas, there is evidence of growth down into adjacent crypts (top-down).

INTRODUCTION

The colorectal adenoma is an important lesion. The concept of the adenoma:carcinoma sequence, whereby such adenomas develop into carcinomas, is well established (1) , and, outside inflammatory bowel disease, most colorectal carcinomas are believed to originate from the adenoma. Consequently, screening programs depend on the removal of these preinvasive lesions at either colonoscopy or sigmoidoscopy. Thus understanding the molecular pathology of the adenoma, its origin, and its mode of growth or expansion becomes equally important.

The initial genetic change in the development of most colorectal adenomas is thought to be at the APC locus, and the molecular events associated with these stages are clear: a second hit in the APC gene is sufficient to give microadenoma development, at least in FAP 2 (2) . There are basically two models for adenoma morphogenesis: in the first, recently reformulated, mutant cells appear in the intracryptal zone between crypt orifices; and, as the clone expands, the cells migrate laterally and downwards to displace the normal epithelium of adjacent crypts (3) . A slight modification of this proposal is that a mutant cell in the crypt base, classically the site of the stem cell compartment (4) , migrates to the crypt apex, where it expands as before. These proposals are based on findings in some early non-FAP adenomas, where dysplastic cells were seen only at the orifices and luminal surface of colonic crypts (3) ; assessment of LOH for APC and nucleotide sequence analysis of the mutation cluster region of the APC gene was applied to microdissected, well-orientated histological sections of these adenomas. Half the sample showed LOH in the upper portion of the crypts, and most of these had a truncating APC mutation. Those cases without LOH showed a truncating mutation, again confined to the dysplastic epithelium at the crypt apex. Moreover, only these superficial cells showed intense proliferative activity, with nuclear localization of β-catenin, supporting the presence of an APC mutation in these apical, dysplastic cells. Several previous morphological studies have drawn attention to the same appearances, including those in FAP (5) . Such a “top-down morphogenesis” has profound implications for concepts of stem cell biology in the gut. Most evidence indicates that crypt stem cells are found at the origin of the cell flux, near the crypt base (6) . Their repertoire includes all crypt cell lineages, metaplastic and reparative cell lineages, the genesis of new crypts, and, as is widely believed, gastrointestinal tumors (4 , 6) . These proposals by Shih et al. (3) either reestablish the stem cell compartment in the intracryptal zone or make the intracryptal zone a locus where stem cells, having acquired a second hit, clonally expand.

An alternative hypothesis involves the recognition of the earliest lesion, the unicryptal or monocryptal adenoma, where the dysplastic epithelium occupies an entire single crypt (7) . These lesions are very common in FAP, and although they are rare in non-FAP patients, they have certainly been described (8) . Here a stem cell apparently acquires a second hit and expands (either stochastically or more probably because of a selective advantage, to colonize the entire crypt). Such monocryptal lesions thus should be clonal (9) . Similar crypt-restricted expansion of mutated stem cells has been well documented in mice after ethyl nitrosurea (ENU) treatment (10) and also in humans heterozygous for the OATgene, where, after LOH, initially half and then the whole crypt is colonized by the progeny of the mutant stem cell (11) . Interestingly, OAT+/OAT− individuals with FAP show increased rates of stem cell mutation with clustering of mutated crypts (12) . In this scenario, in sharp contrast, the mutated clone further expands, not by lateral migration but by crypt fission, where the crypt divides, usually symmetrically at the base, or by budding (Fig. 1A) ⇓ . In several studies, fission of adenomatous crypts is regarded as the main mode of adenoma progression, certainly in FAP, where such events are readily evaluated (13 , 14) , but also in sporadic adenomas (15) . In fact, the nonadenomatous mucosa in FAP, with only one APC mutation, shows a large increase in the incidence of crypts in fission (13) . Aberrant crypt foci, lesions that are putative precursors of adenomas, which can show k-RAS and APCmutations (16) , grow by crypt fission (17 , 18) , as do hyperplastic polyps (19) . But this concept does not exclude the possibility that the clone later expands by lateral migration and downwards spread into adjacent crypts, with the initial lesion being the monocryptal adenoma; however, this model of morphogenesis is conceptually very different from that proposed from Shih et al. (3)

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

A, scheme for crypt fission and examples of a microdissected single crypt and a bifurcating crypt. i–iii, the process of mutational crypt clearance after injection of ethylnitrosourea. i, hemicryptal loss of glucose-6-phosphate dehydrogenase (G6PD) staining; ii, monoclonal conversion of the whole crypt to the mutated phenotype; iii, expansion of the mutant clone to a patch of eight crypts, by the process of crypt fission (from Ref. 10 , with permission). B–D show β-catenin in the nuclei of adenomatous crypts. E shows that nuclear β-catenin extends to the bottom of crypts in early adenomas, including the very bases of the crypts. F and G, β-catenin in nuclei of budding crypts. H, adenomatous crypts from a larger adenoma stained for β-catenin showing invasion of adjacent crypt territories in a top-down fashion. I, widespread distribution of MIB-1 staining in the crypts of early adenomas. J, another area showing surface continuity between crypts with nuclear β-catenin staining. K, the junction of an adenomatous crypt in an early adenoma with the surface epithelium, showing a sharp junction where the nuclear accumulation of β-catenin gives way to membrane staining in the normal surface cells. L, the next serial section (to K), demonstrating the sharp junction between the nuclear staining in the adenomatous cells and the membrane staining in the normal surface cells.

Here we analyze very early sporadic adenomas and the earliest lesions we could identify in cases of FAP, and we conclude that (a) the earliest lesion in the development of both sporadic and FAP adenomas is likely to be the monocryptal adenoma, (b) early clonal expansion is through crypt fission, and (c) spread via the surface is likely to be a phenomenon confined to the later stages of evolution of colorectal adenomas.

MATERIALS AND METHODS

Early Sporadic Adenomas.

Forty tiny (≤3 mm in diameter) tubular adenomas were available from 26 patients and removed at colonoscopy. The procedures were performed on routine endoscopy lists for a variety of clinical reasons (e.g., anemia, altered bowel habit). Three other tubular adenomas of larger size were also studied (up to 1 cm in diameter). The tissues were embedded in Paraplast, and serial sections were cut at a thickness of 4 μm. They were then stained with hematoxylin, for β-catenin (Transduction Laboratory, Becton Dickinson, Middlesex, United Kingdom), and for Ki67 using the MIB-1 antibody (Dako Ltd., Cambridgeshire, United Kingdom; Ref. 20 ). Immunohistochemistry was performed using the streptavidin-biotin immunoperoxidase method. Sections were dewaxed, rehydrated, and incubated with 0.3% hydrogen peroxide (H2O2) for 30 min to block for endogenous peroxidase activity. Antigen retrieval was performed by microwave exposure in 0.01 m citrate buffer (pH 6.0) at 750 W. After microwaving for 10 min, the sections were incubated in anti-β-catenin (mouse monoclonal antibody) for 35 min at a concentration of 1:100. They were then washed in PBS before incubation with biotinylated rabbit antimouse antibody (1:300; Dako) for 30 min, washed in PBS, and then incubated with streptavidin-peroxidase conjugate (1:500; Dako) for an additional 30 min. The sections were developed with 3,3′-diaminobenzidine-tetrahydrochloride (Sigma-Aldrich, Dorset, United Kingdom) and 0.1% H2O2 solution for 2 min and counterstained with hematoxylin. MIB-1 was used at a concentration of 1:100, again after microwaving for antigen retrieval (20 min). The secondary and tertiary layers were as described with β-catenin. For negative controls, duplicate sections were used in which the primary antibodies were omitted and replaced with PBS.

Microdissected Material.

Small (<10 mm) fresh adenomas and normal colonic mucosa were obtained by endoscopic means during colonoscopy after informed written consent. The clinical indications were similar to those of the early adenoma group. Part of the colonic polyps were fixed in formalin and sent for routine histological examination. Ten adenomas (six tubular adenomas and four tubulovillous adenomas) were available for study. Noninvolved colonic mucosa 10–15 cm away from the lesions was also studied. These adenomas have been used in a previous study by Wong et al. (21) . In addition, five samples of normal colonic mucosa from patients with normal colonoscopic findings were used as controls.

Individual crypts were microdissected using the method described by Goodlad et al. (22) . The tissue was taken from its storage in 70% ethanol, hydrated (in 50% ethanol for 10 min followed by 25% ethanol for 10 min), and hydrolyzed in 1 m HCl at 60°C for 10 min. It was then stained by Feulgen reaction for at least 45 min. The tissue was transferred onto a slide with 45% acetic acid and gently teased apart under a dissecting microscope (at ×25 magnification). A coverslip was then placed over the wet tissue and tapped until the crypts began to separate.

FAP Adenomas.

Paraffin-embedded tissues from three cases of FAP who had undergone total prophylactic colectomy were studied. Fifteen blocks (Swiss rolls to identify both the flat mucosa and the adenomas) were embedded from each patient, with approximately 20 serial sections taken from each block at several levels. Serial sections were cut at 4 μm and stained with H&E.

In Situ Hybridization.

Tissue was also available from the XO/XY patient we have described previously (9) . More sections were cut at 4 μm and underwent in situ hybridization for the Y chromosome as described in the same article.

RESULTS

Early Sporadic Adenomas: Histological Studies.

These tubular adenomas consisted of straight or coiled tubules, filled with cells showing varying degrees of atypia. All adenomas examined showed evidence of budding (Fig. 1, F and G) ⇓ , and careful examination showed that all adenomas also show multiple buds in some crypts. In accord with the literature, 40% of the adenomas showed nuclear accumulation of β-catenin (Ref. 23 ; Fig. 1, B–E ⇓ ), suggesting that loss of function in one of the genes in the Wnt pathway, most likely APC, has occurred with subsequent translocation of β-catenin to the nucleus. Closer examination of serial sections shows that the β-catenin nuclear staining extends to the bottom of the adenomatous crypts (Fig. 1, B–E) ⇓ and is present in crypts in the process of crypt fission (Fig. 1, F and G) ⇓ ; β-catenin expression is particularly marked in the nuclei of buds. Moreover, at the surface, there is a sharp cutoff between the adenomatous cells filling the crypt and showing nuclear β-catenin and surface cells that do not (Fig. 1, K and L) ⇓ . In some areas, however, the margins were not discrete, and cells with nuclei containing β-catenin were seen on the surface in continuity with similar cells emerging from an adjacent crypt (Fig. 1J) ⇓ ; however, it is noteworthy that these adjacent crypts are filled with dysplastic cells containing nuclear β-catenin, and not merely confined to the upper portions of the crypts. On the other hand, in larger adenomas, there is unequivocal evidence of surface cells growing down and replacing the epithelium of normal-looking crypts (Fig. 1H) ⇓ .

These changes are frequently associated with increased cell proliferation (Fig. 1I) ⇓ , but the proliferative activity, as evidenced by MIB-1 nuclear staining, is distributed throughout the adenomatous crypts and not confined to the upper parts.

Early Sporadic Adenomas: Microdissection Studies.

Crypt fission was rare in normal and noninvolved mucosa and began with basal bifurcation at the base of the gland (Fig. 2A) ⇓ . In adenomas, fission was mostly asymmetrical (Fig. 2B) ⇓ . Budding from the superficial and mid-crypt was commonly seen (Fig. 2B) ⇓ , in contrast with normal controls, in which all budding was basal, multiple fission events were commonly observed in adenomas (Fig. 2C) ⇓ . The crypt fission index (proportion of crypts in fission) for adenomas at 48% was significantly greater than that for noninvolved mucosa (3%). This difference was significant (P < 0.001).

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

A–C, microdissected crypts from normal colonic mucosae and adenomas. A, symmetrical fission of normal colonic crypts. B, a crypt isolated from an adenoma. Crypt fission was very frequent with atypical and asymmetrical branching. C, another crypt from an adenoma; the crypts have a bizarre shape, asymmetrical branching, and multiple budding. D, a monocryptal adenoma from a case of FAP, showing extension of the adenomatous epithelium from the crypt base to the surface. E, a monocryptal adenoma showing multiple budding. F, monocryptal adenoma with sharp junction between adenomatous cells and surface mucosa. G, the sharp junction where the adenoma meets the surface. H, a monocryptal adenoma from a non-FAP patient (reproduced from Ref. 8 with permission).

FAP Adenomas: Histological Studies.

The earliest lesion identified in FAP is the monocryptal adenoma, a crypt that is completely filled with adenomatous epithelium (Fig. 2D) ⇓ . In the material examined from the three FAP patients, more than 100 adenomas (both monocryptal and established) were observed. In some instances, it can be seen that where the adenomatous crypt is relatively straight and sections are well orientated, the adenomatous epithelium extends to the crypt base, in accord with our previous three-dimensional observations (13) . Moreover, in these monocryptal lesions, the junction between the adenomatous cells and the surface mucosa is sharp (Fig. 2, F and G) ⇓ . More developed adenomas showed evidence of crypt fission and budding (Fig. 2E) ⇓ .

FAP Adenomas: In Situ Hybridization Studies.

In the XO/XY individual, more than 12,000 crypts were examined, and all were either Y chromosome positive (XY crypts) or Y chromosome negative (XO crypts). No mixed crypts were found at patch borders in over 1,000 crypts counted, and hence the colonic crypts are clonal (9) . Individual adenomas were small, not exceeding 2.5 mm in diameter.

Fig. 3A ⇓ shows 1 of the 93 monocryptal adenomas we examined in this patient, and Fig. 3B ⇓ shows such a monocryptal adenoma stained for the Y chromosome: all nuclei are positive. These monocryptal adenomas all showed either the XO or XY genotype, with no mixed monocryptal adenomas being seen. Thus all such lesions are clonal proliferations, as would be expected from the observation that all crypts are clonal (9) . Fig. 3C ⇓ shows a low-power photograph of a microadenoma from this patient, with several adenomatous crypts filled with atypical cells (Fig. 3D) ⇓ . Fig. 3E ⇓ , of a serial section, shows that the nuclei of some adenomatous crypts stain for the Y chromosome (Fig. 3G) ⇓ , whereas others are negative, except for an occasional infiltrating lymphocyte (Fig. 3H) ⇓ . Thus this microadenoma is polyclonal, composed of adenomatous crypts of both XO and XY phenotype; in fact, 76% of adenomas in this patient were polyclonal (9) . Importantly, Fig. 3F ⇓ , an enlarged field from Fig. 3E ⇓ , shows an XY adenomatous crypt approaching the mucosal surface, in immediate juxtaposition to the point at which an XO adenomatous crypt also emerges at the surface. Note that the Y chromosome-positive nuclei stop sharply at the surface and do not encroach into the XO adenomatous crypt territory, indicating that there is no evidence that adenomatous cells migrate superficially over the surface to occupy other crypts. Furthermore, in none of the 260 more established adenomas were we able to demonstrate a mixture of XY and XO cells occupying the same crypt.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Colonic sections of a XO/XY individual with FAP. A, H&E staining of a monocryptal adenoma. B, NISH staining for the Y chromosome revealing clonality of a monocryptal adenoma. C, H&E-stained section of a microadenoma. D, high-power view of C showing dysplastic cells in multiple adenomatous crypts. E, adjacent section with non-isotopic in situ hybridisation (NISH) staining for the Y chromosome showing adenomatous crypts [two without Y chromosome staining (XO crypts) and three with Y chromosome staining (XY crypts)]. F–H, high-power views of the labelled adenomatous crypts from E; note the sharp demarcation of Y-positive epithelium showing no overgrowth either way (E and F).

Because parts of the Y chromosome in this individual are duplicated, note that the paint shows 2 dots/nucleus if the section is appropriately orientated.

DISCUSSION

There are several conclusions made possible by these studies.

(a) In early sporadic adenomas, adenomatous crypts appear as discrete entities. Adenomatous cells fill the entire crypt and appear to stop sharply at the junction with the surface epithelium. Spread out onto the surface into surrounding nonadenomatous crypts is not seen. Adjacent adenomatous crypts, however, are sometimes joined at the surface by adenomatous cells. This supports expansion by crypt fission, and not top-down spread (see Fig. 1 ⇓ ).

(b) Crypts in early adenomas display a proliferative architecture, where proliferating cells are seen throughout the crypt, with a reduction in MIB-1 labeling as the surface approaches (Fig. 1I) ⇓ . This in accord with our observations on the distribution of mitoses in microdissected adenomatous crypts (21) . This again suggests that crypts in early adenomas are discrete entities and replicate the stem cell/transit amplifying/differentiating cell organization seen in normal crypts and supported by studies on the methylation history of adenomas (24) . Such an organization does not support the concept that cells grow downwards from the surface to occupy new, uninvolved crypts.

(c) Adenomatous crypts in such early lesions are the site of remarkable fission and budding activity (Fig. 1, F and G ⇓ ; Fig. 2, B and C ⇓ ), suggesting that the main mode of expansion is by fission of preexisting adenomatous crypts.

(d) The earliest lesion detectable in FAP mucosa is the monocryptal adenoma. Again, there is a sharp delineation at the surface between adenomatous and surface cells (Fig. 2F) ⇓ . Monocryptal adenomas expand by fission (Fig. 2E) ⇓ , and lesions larger than one crypt in size show multiple fission events. The monocryptal adenoma appears to be a clonal proliferation, consistent with origin in a single clonal crypt (Fig. 3, A and B) ⇓ . Observations on the margins of small FAP adenomas show no evidence of adenomatous cells of one genotype invading crypt territories of another genotype (Fig. 3, E and F) ⇓ .

The overall conclusion from these studies is that the major mode of clonal expansion in early adenomas is by crypt fission or budding.

If we regard FAP as a model for sporadic colorectal cancer, then the evolution of the monocryptal adenoma to an early microadenoma by crypt fission would also apply. Whereas monocryptal adenomas in non-FAP patients are of course rare, they have been described (Ref. 8 ; Fig. 2H ⇓ ), and there is certainly no reason not to propose that the early growth of sporadic adenomas is similar, as Fig. 1, F and G ⇓ , would suggest. But does top-down spread occur in adenomas? Of course it does: Shih et al. (3) demonstrate this very convincingly, and such appearances are indeed common at the margins of larger sporadic adenomas. In fact, there is evidence that can be interpreted in favor of this mode of expansion in FAP as well. Bjerknes et al. (25) showed that adenomatous crypts in FAP contained two stem cell lines, APC−/+ and APC−/−, although they interpreted this to mean that the APC−/− cells were expanding stochastically within the same crypt, rather than growing in from outside. There is good evidence that such monoclonal conversion occurs as a stochastic process (10) . However, Wasan et al. (13) , studying larger FAP adenomas by three-dimensional reconstruction, were able to demonstrate adenomatous crypts in direct continuity with nonadenomatous crypts, which of course would be consistent with top-down expansion.

In addition to the sharp junctions at the top of adenomatous crypts, there are instances where cells with β-catenin-containing nuclei are in continuity on the surface (Fig. 1J) ⇓ . However, the contributing crypts are wholly occupied by similar cells, and these are not confined to the superficial aspects of the crypts. This would be consistent with crypts dividing but not totally separating, as suggested by previous three-dimensional studies (see Fig. 5C in Ref. 13 ).

It is worthwhile asking the question—what are the implications of the top-down and bottom-up proposals for studies of clonality in colorectal adenomas? Herein lies a conundrum. In the top-down scenario, adenomatous cells, presumably of clonal origin, spread from the putative stem cell niche on the surface of the mucosa laterally and downwards to involve multiple adjacent crypts. Fig. 1C ⇓ in Shih et al. (3) and Fig. 1H ⇓ in this article show that many crypts are partially involved by the adenomatous epithelium. Because crypts are clonal units, this would suggest that these lesions would be polyclonal, because of the mixture of clonal crypts and clonal adenoma, although of different clonal derivation. In fact studies from the same laboratory of 50 sporadic and FAP adenomas, using X-linked RFLPs, showed that these lesions were monoclonal in origin (26) . How can this be? Recent studies by Novelli et al. (27) have shown that the X-linked patch size in the colon is large and can be in excess of 450 crypts in diameter. So, unless an adenoma grows out over a patch boundary and involves crypts on either side of that boundary, X-inactivation analysis will always show that such lesions are monoclonal.

What about the clonal implications of the bottom-up proposals? Expansion of a clonal monocryptal adenoma (Fig. 2E) ⇓ by crypt fission would inevitably lead to a monoclonal microadenoma and adenoma. However, studies on the XO/XY individual, who has a mean patch size of 1.48 crypts, further studied here, indicated that some 76% of adenomas were polyclonal (9) , a result supported by observations in Rosa26/Min chimeric mice (28) . So, how can this be explained? Possible mechanisms include the adenomatous transformation of noninvolved crypts under the influence of transformed crypts (28) ; in fact, this was the explanation chosen for the observation that normal crypts were apparently seen in direct continuity with transformed crypts (see Ref. 13 , and see above).

Adenomatous crypts in sporadic adenomas show superficial similarities to normal crypts in the distribution of their proliferative activity. Observations on other, possibly older adenomas have indicated that maximum proliferative activity is found toward the top of the crypts, with the implication that migration kinetics are reversed, with the flux directed toward the bottom of the crypt (29 , 30) . These observations are backed up by the finding of increased apoptosis at the bottom of adenomatous crypts (29 , 31) . Such a distribution could support a top-down scenario. In this respect, perhaps counterintuitively, there is evidence from examining the methylation histories of cells in adenomas for a discrete stem cell architecture (24) . We have reported previously that crypt mitotic scores were significantly greater in adenomas compared with noninvolved mucosae and normal controls (21) . The crypt fission index (proportion of crypts in fission) for adenomas was significantly greater than that of noninvolved mucosae and normal controls. Moreover, studying the zonal distribution of mitoses in adenomas, noninvolved mucosae, and normal controls, we have shown that in normal colonic mucosae, the mitotic figures were located mainly in zones 1 and 2, that is, the base of the crypts (21) . In adenomas, mitoses were almost evenly distributed between the five zones. This does not suggest a concentration of dysplastic cells in the tops of adenomatous crypts, as suggested by Fig. 1C ⇓ of Shih et al. (3) , nor is it consistent with the positional observations of Moss et al. (29) , using proliferation markers in histological sections. This difference in our results may reflect the difference in techniques because we observed whole crypts after microdissection, which avoids potential geometric artifact imposed by observing sectioned crypts (32) . Our previous work on the distribution of mitoses in the flat mucosae of FAP patients failed to demonstrate the upward expansion of the proliferative zone reported previously in histological sections using tritiated thymidine by Lipkin et al. (33) .

Where adenomas arise, in respect to the crypt and its component cell populations, is important from the viewpoint of the location of the stem cell and the potential target cells for carcinogens in the colon. In the Shih et al. (3) concept, either the stem cell is located on the surface of the colon or the stem cell is located in the classic site, in the crypt base, but adenomatous transformation is not manifest until the transformed stem cell reaches the surface and clonally expands. Whereas this is not the place to review the evidence, there is very strong support for a stem cell niche in the crypt base (34) . On the bottom-up proposal, transformation takes place among the stem cell population in the crypt base, the transformed stem cell expands stochastically, and monoclonal conversion gives the monocryptal adenoma, which itself expands early by crypt fission and later by overgrowing adjacent crypts as well.

Others have also concluded that migrating crypt epithelial cells in the upper part of the crypt are the primary targets for transformation by APC mutation (35) , and this has received some experimental support (36) . In this latter publication, van der Wetering et al. (36) suggest that at the bottom of the crypt, progenitor cells accumulate nuclear β-catenin and express Tcf target genes as a result of Wnt stimulation from surrounding basal pericryptal myofibroblasts. In normal crypts, cells that reach the mid-crypt region down-regulate β-catenin/Tcf, resulting in cell cycle arrest and differentiation. Cells that carry a β-catenin or APC mutation do not respond to signals controlling β-catenin/Tcf activity, and these cells continue to behave as crypt progenitor cells in the surface epithelium, giving rise to microadenomas. However, two phenomena that are not addressed by the Shih et al. (3) concept are (a) the monocryptal adenoma in FAP and sporadic cases and (b) where the ramifying and budding tubules seen so commonly in adenomas of all varieties come from. As far as the monocryptal adenoma is concerned, there is no apparent explanation that can be proffered within the Shih et al. (3) proposal: an origin from the surface and migration solely into one crypt do not seem feasible. However, with regard to the second problem, it is possible that after the normal crypt territories are completely filled with adenomatous cells, then budding and fission could be a secondary phenomenon. However, our findings of extensive crypt fission in early adenomas would appear to exclude this possibility.

We conclude that crypt fission is an essential event in the clonal expansion of mutated clones in adenomas. Whereas the morphology of this process is quite distinct, the molecular mechanisms that govern it are far from clear. We further conclude that (a) the initial event in the genesis of colorectal adenomas of both sporadic and FAP adenomas is the monocryptal adenoma, (b) initial growth occurs via crypt fission, and (c) spread into adjacent crypt territories is a later, secondary event.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • ↵1 To whom requests for reprints should be addressed, at Histopathology Unit, London Research Institute, Cancer Research UK, 44 Lincoln’s Inn Field, London WC2A 3PX, United Kingdom.

  • ↵2 The abbreviations used are: FAP, familial adenomatous polyposis; LOH, loss of heterozygosity; OAT, O-acetyl transferase.

  • Received January 22, 2003.
  • Accepted May 1, 2003.
  • ©2003 American Association for Cancer Research.

References

  1. ↵
    Morson B. C. Evolution of cancer of the colon and rectum. Cancer (Phila.), 34: ((Suppl.)) 845-849, 1974.
    OpenUrlCrossRefPubMed
  2. ↵
    Lamlum H., Papadopoulou A., Ilyas M., Rowan A., Gillet C., Hanby A., Talbot I., Bodmer W., Tomlinson I. APC mutations are sufficient for the growth of early colorectal adenomas. Proc. Natl. Acad. Sci. USA, 97: 2225-2228, 2000.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Shih I. M., Wang T. L., Traverso G., Romans K., Hamilton S. R., Ben-Sasson S., Kinzler K. W., Vogelstein B. Top-down morphogenesis of colorectal tumors. Proc. Natl. Acad. Sci. USA, 98: 2640-2645, 2001.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Wright N. A. Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer. Int. J. Exp. Pathol., 81: 117-143, 2000.
    OpenUrlCrossRefPubMed
  5. ↵
    Maskens A. P. Histogenesis of adenomatous polyps in the human large intestine. Gastroenterology, 77: 1245-1251, 1979.
    OpenUrlPubMed
  6. ↵
    Bjerknes M., Cheng H. Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology, 116: 7-14, 1999.
    OpenUrlCrossRefPubMed
  7. ↵
    Nakamura S., Kino I. Morphogenesis of minute adenomas in familial polyposis coli. J. Natl. Cancer Inst. (Bethesda), 73: 41-49, 1984.
    OpenUrlPubMed
  8. ↵
    Woda B. A., Forde K., Lane N. A unicryptal colonic adenoma, the smallest colonic neoplasm yet observed in a non-polyposis individual. Am. J. Clin. Pathol., 68: 631-632, 1977.
    OpenUrlPubMed
  9. ↵
    Novelli M. R., Williamson J. A., Tomlinson I. P., Elia G., Hodgson S. V., Talbot I. C., Bodmer W. F., Wright N. A., Fukui M., Fujino T., Tsutsui K., Maruyama T., Yoshimura H., Shinohara T., Nada O. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (Wash. DC), 272: 1187-1190, 1996.
    OpenUrlAbstract
  10. ↵
    Park H. S., Goodlad R. A., Wright N. A. Crypt fission in the small intestine and colon.A mechanism for the emergence of G6PD locus-mutated crypts after treatment with mutagens. Am. J. Pathol., 147: 1416-1427, 1995.
    OpenUrlPubMed
  11. ↵
    Campbell F., Williams G. T., Appleton M. A., Dixon M. F., Harris M., Williams E. D. Post-irradiation somatic mutation and clonal stabilisation time in the human colon. Gut, 39: 569-573, 1996.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Campbell F., Geraghty J. M., Appleton M. A., Williams E. D., Williams G. T. Increased stem cell somatic mutation in the non-neoplastic colorectal mucosa of patients with familial adenomatous polyposis. Hum. Pathol., 29: 1531-1535, 1998.
    OpenUrlCrossRefPubMed
  13. ↵
    Wasan H. S., Park H. S., Liu K. C., Mandir N. K., Winnett A., Sasieni P., Bodmer W. F., Goodlad R. A., Wright N. A. APC in the regulation of intestinal crypt fission. J. Pathol., 185: 246-255, 1998.
    OpenUrlCrossRefPubMed
  14. ↵
    Chang W. W., Whitener C. J. Histogenesis of tubular adenomas in hereditary colonic adenomatous polyposis. Arch. Pathol. Lab. Med., 113: 1042-1049, 1989.
    OpenUrlPubMed
  15. ↵
    Wong W. M., Garcia S. B., Wright N. A. Origins and morphogenesis of colorectal neoplasms. APMIS, 107: 535-544, 1999.
    OpenUrlPubMed
  16. ↵
    Smith A. J., Stern H. S., Penner M., Hay K., Mitri A., Bapat B. V., Gallinger S. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res, 54: 5527-5530, 1994.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Fujimitsu Y., Nakanishi H., Inada K., Yamachika T., Ichinose M., Fukami H., Tatematsu M. Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts. Jpn. J. Cancer Res., 87: 1199-1203, 1996.
    OpenUrlCrossRefPubMed
  18. ↵
    Siu I. M., Robinson D. R., Schwartz S., Kung H. J., Pretlow T. G., Petersen R. B., Pretlow T. P. The identification of monoclonality in human aberrant crypt foci. Cancer Res, 59: 63-66, 1999.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Araki K., Ogata T., Kobayashi M., Yatani R. A morphological study on the histogenesis of human colorectal hyperplastic polyps. Gastroenterology, 109: 1468-1474, 1995.
    OpenUrlCrossRefPubMed
  20. ↵
    Wong W. M., Stamp G. W., Elia G., Poulsom R., Wright N. A. Proliferative populations in intestinal metaplasia: evidence of deregulation in Paneth and goblet cells, but not endocrine cells. J. Pathol., 190: 107-113, 2000.
    OpenUrlCrossRefPubMed
  21. ↵
    Wong W. M., Mandir N., Goodlad R. A., Wong B. C., Garcia S. B., Lam S. K., Wright N. A. Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut, 50: 212-217, 2002.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Goodlad R. A., Levi S., Lee C. Y., Mandir N., Hodgson H., Wright N. A. Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique. Gastroenterology, 101: 1235-1241, 1991.
    OpenUrlPubMed
  23. ↵
    Hao X., Frayling I. M., Willcocks T. C., Han W., Tomlinson I. P., Pignatelli M. N., Pretlow T. P., Talbot I. C. β-Catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis. Virchows Arch., 440: 362-366, 2002.
    OpenUrlCrossRefPubMed
  24. ↵
    Tsao J. L., Zhang J., Salovaara R., Li Z. H., Jarvinen H. J., Mecklin J. P., Aaltonen L. A., Shibata D. Tracing cell fates in human colorectal tumors from somatic microsatellite mutations: evidence of adenomas with stem cell architecture. Am. J. Pathol., 153: 1189-1200, 1998.
    OpenUrlCrossRefPubMed
  25. ↵
    Bjerknes M., Cheng H., Kim H., Schnitzler M., Gallinger S. Clonality of dysplastic epithelium in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res., 57: 355-361, 1997.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Fearon E. R., Hamilton S. R., Vogelstein B. Clonal analysis of human colorectal tumors. Science (Wash. DC), 238: 193-197, 1987.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Novelli M. R., Cossu A., Tomlinson I., Poulsom R., Bodmer W., Tanda F., Wright N. A. Patch size in the human colon confounds the assessment of tumour clonality using X chromosome-linked markers. Proc. Natl. Acad. Sci. USA, 100: 3311-3314, 2003.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Merritt A. J., Gould K. A., Dove W. F. Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages. Proc. Natl. Acad. Sci. USA, 94: 13927-13931, 1997.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Moss S. F., Liu T. C., Petrotos A., Hsu T. M., Gold L. I., Holt P. R. Inward growth of colonic adenomatous polyps. Gastroenterology, 111: 1425-1432, 1996.
    OpenUrlCrossRefPubMed
  30. ↵
    Shiff S. J., Rigas B. Colon adenomatous polyps: do they grow inward?. Lancet, 349: 1853-1854, 1997.
    OpenUrlCrossRefPubMed
  31. ↵
    Sinicrope F. A., Roddey G., McDonnell T. J., Shen Y., Cleary K. R., Stephens L. C. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin. Cancer Res., 2: 1999-2006, 1996.
    OpenUrlAbstract
  32. ↵
    Wright N. A., Alison M. R. . The Biology of Epithelial Cell Populations, Vol. 1: Oxford University Press Oxford, United Kingdom 1984.
  33. ↵
    Lipkin M., Blattner W. A., Gardner E. J., Burt R. W., Lynch H., Deschner E., Winawer S., Fraumeni J. F., Jr. Classification and risk assessment of individuals with familial polyposis, Gardner’s syndrome, and familial non-polyposis colon cancer from [3H]thymidine labeling patterns in colonic epithelial cells. Cancer Res., 44: 4201-4207, 1984.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Mills J. C., Gordon J. I. The intestinal stem cell niche: there grows the neighborhood. Proc. Natl. Acad. Sci. USA, 98: 12334-12336, 2001.
    OpenUrlFREE Full Text
  35. ↵
    Lamprecht S. A., Lipkin M. Migrating colonic crypt epithelial cells: primary targets for transformation. Carcinogenesis (Lond.), 23: 1777-1780, 2002.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A. P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., Clevers H. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111: 241-250, 2002.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Cancer Research: 63 (13)
July 2003
Volume 63, Issue 13
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Bottom-up Histogenesis of Colorectal Adenomas
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Bottom-up Histogenesis of Colorectal Adenomas
Sean L. Preston, Wai-Man Wong, Annie On-On Chan, Richard Poulsom, Rosemary Jeffery, Robert A. Goodlad, Nikki Mandir, George Elia, Marco Novelli, Walter F. Bodmer, Ian P. Tomlinson and Nicholas A. Wright
Cancer Res July 1 2003 (63) (13) 3819-3825;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Bottom-up Histogenesis of Colorectal Adenomas
Sean L. Preston, Wai-Man Wong, Annie On-On Chan, Richard Poulsom, Rosemary Jeffery, Robert A. Goodlad, Nikki Mandir, George Elia, Marco Novelli, Walter F. Bodmer, Ian P. Tomlinson and Nicholas A. Wright
Cancer Res July 1 2003 (63) (13) 3819-3825;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Abstract 6119: RNAi rat models for drug discovery
  • Abstract 3834: Histone methyltransferase SET8 is regulated by miR-192/-215 and induces oncogene-induced senescence via p53-dependent DNA damage in human gastric carcinoma cells
  • Abstract 3788: CircHMGCS1 interacts with RNA binding protein HuR and maintains stem-like cells in gliomas
Show more Tumor Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement